Short answer
Orthofix Medical Inc. (OFIX) filed its Q1 2026 10-Q quarterly report on May 5, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $197M (up 1.6% year over year) with net income of −$21M.
Q1 2026 key financials · XBRL
- Revenue
- $197M
- +1.6% YoY
- Net income
- −$21M
- +60.6% YoY
- Operating margin
- -7.3%
- Gross margin
- 70.9%
- EPS (diluted)
- −$0.52
- +61.5% YoY
Source: XBRL data from the Orthofix Medical Inc. (OFIX) Q1 2026 10-Q on SEC EDGAR. USD.
Orthofix Medical Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No risk-factors section provided; supplied text begins with Item 2, “Unregistered Sales of Equity Securities and Use of Proceeds”
- No new or changed risk factors identifiable from the provided excerpt
- No regulatory, legal, operational, competitive, market, liquidity, debt, currency, or concentration risks disclosed in the excerpt
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Orthofix Medical Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.